Australia markets closed

Tiziana Life Sciences Ltd (0RP.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.7550-0.0300 (-3.82%)
As of 08:09AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Cost of revenue
0
-
-
0
0
0
Gross profit
0
-
-
0
0
0
Operating expenses
Research development
8,113
8,113
12,955
13,208
5,993
-
Selling general and administrative
0
0
0
855
13,214
-
Total operating expenses
17,984
17,984
14,586
27,374
30,410
-
Operating income or loss
-17,984
-17,984
-14,586
-27,374
-30,410
-
Interest expense
10
10
7
176
320
-
Total other income/expenses net
-402
-402
-804
893
2,384
-
Income before tax
-17,242
-17,242
-15,397
-26,657
-28,338
-
Income tax expense
449
449
0
-3,240
-2,207
-
Income from continuing operations
-17,691
-17,691
-15,397
-23,417
-26,131
-
Net income
-17,691
-17,691
-15,397
-23,417
-26,131
-
Net income available to common shareholders
-17,691
-17,691
-15,397
-23,417
-26,131
-
Basic EPS
-0.18
-0.17
-0.15
-0.24
-0.16
-
Diluted EPS
-0.18
-0.17
-0.15
-0.24
-0.16
-
Basic average shares
103,697
102,471
101,526
97,932
169,065
-
Diluted average shares
103,697
102,471
101,526
97,932
169,065
-